| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |